Search for: "In re: Avandia Marketing Sales v."
Results 21 - 40
of 41
Sort by Relevance
|
Sort by Date
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
5 Sep 2013, 12:24 pm
June 1, 2012); In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
17 Jul 2013, 8:50 am
In re Avandia Marketing, Sales and Products Liab. [read post]
9 May 2013, 3:31 am
Supreme Court’s denial of certiorari on an appeal of the Third Circuit’s decision in In Re Avandia Marketing Sales Practices GlaxoSmithKline LLC v. [read post]
25 Apr 2013, 5:00 am
May 18, 2012) (motion to amend) – pharmacy liability, express and implied warrantiesIn Re Yasmin and Yaz Marketing, Sales Practices & Products Liability Litigation, 870 F. [read post]
19 Apr 2013, 5:35 pm
See, e.g., In re Avandia Marketing, Sales Practices & Prod. [read post]
2 Jul 2012, 11:57 am
In In re Avandia Marketing, Sales Practices and Products Liability Litigation, the court held that the Medicare Secondary Payer Act (“MSP”) provides Medicare Advantage Organizations (“MAOs”) with a private cause action to seek recovery against a primary payer (such as a liability insurer or self-insured defendant in a personal injury matter) in Federal court. [read post]
2 Jul 2012, 11:57 am
In In re Avandia Marketing, Sales Practices and Products Liability Litigation, the court held that the Medicare Secondary Payer Act (“MSP”) provides Medicare Advantage Organizations (“MAOs”) with a private cause action to seek recovery against a primary payer (such as a liability insurer or self-insured defendant in a personal injury matter) in Federal court. [read post]
29 Feb 2012, 8:25 am
Even in these relatively low-risk groups, there was a trend towards an adverse outcome for Avandia users (e.g., in DREAM, the p-value was .08, which means that there is a 92% likelihood that the difference between the two groups was not the result of mere chance).FN72“ In re Avandia Marketing, Sales Practices and Product Liability Litigation, 2011 WL 13576, *12 (E.D. [read post]
25 Feb 2012, 10:04 am
Supp. 2d 420 (E.D.N.Y. 2011) Avandia In re Avandia Marketing, Sales Practices and Product Liability Litigation, 2011 WL 13576, *12 (E.D. [read post]
14 Nov 2011, 7:13 pm
See also In re Bextra and Celebrex Marketing Sales Practices and Prod. [read post]
21 Jun 2011, 7:30 am
" IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION; THIS DOCUMENT APPLIES TO: Humana v. [read post]
26 Feb 2011, 7:51 am
” In re Avandia Marketing, Sales Practices and Product Liability Litigation, 2011 WL 13576, *12 (E.D. [read post]
24 Jan 2011, 5:35 am
In the MDL court’s opinion on general causation, In re Avandia Marketing, Sales Practices and Product Liability Litigation, 2011 WL 13576 (E.D. [read post]
10 Jan 2011, 8:29 pm
In re Avandia Marketing, Sales Practices, and Products Liab. [read post]
23 Nov 2010, 8:00 am
In the MDL involving the the diabetes medication Avandia, In re Avandia Marketing, Sales Practices, and Products Liab. [read post]
18 Nov 2010, 12:37 pm
Acme Markets, Inc., 2009 WL 1090660 (D.N.J. [read post]
1 Oct 2009, 2:14 am
While we're on the subject, can we get judges to rewrite the New Jersey and Minnesota statutes of limitations to add a borrowing statute? [read post]
6 Jul 2009, 5:30 am
TDI Managed Care Services, Inc., Slip Copy, 2009 WL 653029 (M.D.Ala., Mar 12, 2009)(NO. 2:05-CV-293MEF) In re Avandia Marketing, Sales Practices and Products Liability Litigation, Slip Copy, 2009 WL 498936 (E.D.Pa., Feb 25, 2009)(NO. [read post]
29 Jun 2009, 10:00 pm
We'll try to keep it mercifully brief.In In re Avandia Marketing, Sales Practices and Prods. [read post]
